Rapid Access of Initial HIV Appointment and ART Prescription
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
University of Mississippi Medical Center utilized known barriers to care for postpartum women with HIV and leveraged that information to schedule individualized interactions with pregnant and postpartum women with HIV. This low-cost, low-effort initiative resulted in statistically significant improvements in both retention in care and viral suppression rates in postpartum women with HIV.
Resource (Conference Presentation) updated 09/14/2023
Rapid has developed into a core feature of the Dorothy Mann Center HIV care continuum, assuring immediate linkage to expert HIV services, immediate initiation of therapy, and rapid viral suppression. Benefits are present for youth prevention services. Rapid access models are feasible and beneficial for youth HIV care and prevention.
Resource (Conference Presentation) updated 09/14/2023
This sub-study compared viral suppression between SPNS participants and non-participants at the Meharry site. The SPNS study enrolled women of color newly who were recently diagnosed with HIV or lost to care. There was no statistically significant difference in viral suppression after controlling for demographic and clinical factors.
Resource (Conference Presentation) updated 09/14/2023
A clinic-based substance abuse screening and treatment program is described. Using the Screening, Brief Intervention, and Referral to Treatment model, this provides annual proactive screening of alcohol/drug use, with a brief provider response and a follow-up motivational interviewing brief intervention, with treatment provided by an embedded provider.
Resource (Conference Presentation) updated 09/14/2023
Through creative innovation, multiple approaches have been employed to assist patients with medication adherence. This presentation will look at the introduction of a clinical pharmacist in an urban, Ryan White-funded clinic, the impact on medication adherence, and the viral suppression and demographic trends observed over four years.
Resource (Conference Presentation) updated 09/14/2023
Given rising HIV diagnoses within the Latinx community, this presentation provides a holistic primer on patient-centered care for Latinx folks, de-emphasizing the ‘one size fits all' approach by considering the diversity and cultural nuances within the community. This presentation is for those newly interacting with the Latinx community or those seeking to strengthen existing relationships.
Resource (Conference Presentation) updated 09/14/2023
Leadership Institute Session 1 focuses on the leadership of people with HIV and will cover the role and history of meaningful involvement of people with HIV. It will explore culturally responsive leadership, transformational leadership, and cultural humility. Facilitators will demonstrate formal and informal leadership skills. People with HIV are encouraged to attend.
Resource (Conference Presentation) updated 09/14/2023
Session 2 of the Leadership Institute focuses on stigma and intersectionality. Participants will explore different forms and manifestations of stigma, the impact of stigma on health outcomes, and the tenets of intersectionality. There will be discussion on improving factors contributing to stigma and intersectionality that impact the HIV service delivery system. People with HIV are encouraged to attend.
Resource (Conference Presentation) updated 09/14/2023
Oklahoma has been classified by the Department of Health and Human Services as one of the seven states with a high rural HIV burden. Test-and-treat protocols are feasible within high-volume HIV clinics which serve rural and underserved communities to minimize the time to the first appointment to decrease time to viral load suppression.
Resource (Conference Presentation) updated 09/14/2023
After childbirth, women with HIV are more likely to fall out of care, leading to higher morbidity, risk of transmitting HIV to intimate partners, and subsequent pregnancies. Psychiatric disorders and other barriers are contributors to loss of follow-up. We present the successes and opportunities to improve health outcomes for postpartum women with HIV.
Resource (Conference Presentation) updated 09/14/2023
Undetectable=Untransmittable: individuals who maintain viral suppression don't transmit HIV to their sexual partners. Yet some providers are uncomfortable discussing the implications of viral suppression in clinical encounters. This workshop will explore approaches to reduce provider discomfort in discussing U=U and present strategies to convey this message.
Resource (Conference Presentation) updated 09/14/2023
This presentation assesses social determinants that affect the HIV continuum of care. Establish patterns at the economic, demographic, and sociocultural factors that may fragment or, in a worst-case scenario, interrupt access to HIV testing, biomedical prevention, follow-up to a positive diagnosis, and adherence to treatment.
Resource (Conference Presentation) updated 09/14/2023
This presentation will provide an overview of the potential role of express STI services in HIV prevention and care and improving the clinic efficiency of RWHAP clinics and health centers by developing fast tracks for asymptomatic patients requiring STI testing.
Resource (Conference Presentation) updated 09/14/2023
Prism Health North Texas will share the challenges and successes of adapting Ryan White case management tools and strategies to a pre-exposure prophylaxis (PrEP) program for behavioral intervention. Panelists will detail how they took lessons learned from case management to HIV prevention to become status neutral.
Resource (Conference Presentation) updated 09/14/2023
This session will focus on key findings and behavioral considerations for long-acting antiretroviral treatment (ART) HIV regimens, given the progress in research, development, and potential approval of these drugs. There will be a brief overview of the ATLAS and FLAIR studies, discussion of the medications, and an outline of the potential impact of the regimens on care delivery models, providers, patients, and payers if they are approved.
Resource (Conference Presentation) updated 09/14/2023
Preventing HIV with pre-exposure prophylaxis (PrEP) is a pillar of the Ending the HIV Epidemic initiative. This session will explore PrEP implementation resources for health centers developed by the National LGBT Health Education Center at The Fenway Institute and prepare participants to use and adapt them to their organizations.
Resource (Conference Presentation) updated 09/14/2023